These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 12569610

  • 1. Survival and functional outcome of children with hypothalamic/chiasmatic tumors.
    Fouladi M, Wallace D, Langston JW, Mulhern R, Rose SR, Gajjar A, Sanford RA, Merchant TE, Jenkins JJ, Kun LE, Heideman RL.
    Cancer; 2003 Feb 15; 97(4):1084-92. PubMed ID: 12569610
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.
    Fouladi M, Hunt DL, Pollack IF, Dueckers G, Burger PC, Becker LE, Yates AJ, Gilles FH, Davis RL, Boyett JM, Finlay JL.
    Cancer; 2003 Sep 15; 98(6):1243-52. PubMed ID: 12973849
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.
    Tekautz TM, Fuller CE, Blaney S, Fouladi M, Broniscer A, Merchant TE, Krasin M, Dalton J, Hale G, Kun LE, Wallace D, Gilbertson RJ, Gajjar A.
    J Clin Oncol; 2005 Mar 01; 23(7):1491-9. PubMed ID: 15735125
    [Abstract] [Full Text] [Related]

  • 6. High-grade astrocytoma in very young children.
    Sanders RP, Kocak M, Burger PC, Merchant TE, Gajjar A, Broniscer A.
    Pediatr Blood Cancer; 2007 Dec 01; 49(7):888-93. PubMed ID: 17554787
    [Abstract] [Full Text] [Related]

  • 7. Management of optic chiasmatic/hypothalamic astrocytomas in children.
    Steinbok P, Hentschel S, Almqvist P, Cochrane DD, Poskitt K.
    Can J Neurol Sci; 2002 May 01; 29(2):132-8. PubMed ID: 12035834
    [Abstract] [Full Text] [Related]

  • 8. Ependymal tumors in childhood.
    Agaoglu FY, Ayan I, Dizdar Y, Kebudi R, Gorgun O, Darendeliler E.
    Pediatr Blood Cancer; 2005 Sep 01; 45(3):298-303. PubMed ID: 15770637
    [Abstract] [Full Text] [Related]

  • 9. Natural history and outcome of optic pathway gliomas in children.
    Nicolin G, Parkin P, Mabbott D, Hargrave D, Bartels U, Tabori U, Rutka J, Buncic JR, Bouffet E.
    Pediatr Blood Cancer; 2009 Dec 15; 53(7):1231-7. PubMed ID: 19621457
    [Abstract] [Full Text] [Related]

  • 10. Outcome analysis of childhood low-grade astrocytomas.
    Fisher PG, Tihan T, Goldthwaite PT, Wharam MD, Carson BS, Weingart JD, Repka MX, Cohen KJ, Burger PC.
    Pediatr Blood Cancer; 2008 Aug 15; 51(2):245-50. PubMed ID: 18386785
    [Abstract] [Full Text] [Related]

  • 11. Childhood intracranial ependymoma: twenty-year experience from a single institution.
    Shu HK, Sall WF, Maity A, Tochner ZA, Janss AJ, Belasco JB, Rorke-Adams LB, Phillips PC, Sutton LN, Fisher MJ.
    Cancer; 2007 Jul 15; 110(2):432-41. PubMed ID: 17559078
    [Abstract] [Full Text] [Related]

  • 12. Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update.
    Mishra KK, Squire S, Lamborn K, Banerjee A, Gupta N, Wara WM, Prados MD, Berger MS, Haas-Kogan DA.
    J Neurooncol; 2010 Oct 15; 100(1):121-7. PubMed ID: 20221671
    [Abstract] [Full Text] [Related]

  • 13. [Management of chiasmatic-hypothalamic gliomas in children: report of nine pediatric cases].
    Akiyama H, Nakamizo S, Kawamura A, Nagashima T, Takeda H, Hasegawa D, Kosaka Y, Yoshida M.
    No Shinkei Geka; 2007 Nov 15; 35(11):1079-85. PubMed ID: 18044225
    [Abstract] [Full Text] [Related]

  • 14. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK, Rood B, Kamani N, Lafond D, Perez-Albuerne E, Loechelt B, Packer RJ, MacDonald TJ.
    Pediatr Blood Cancer; 2007 Mar 15; 48(3):278-84. PubMed ID: 16456857
    [Abstract] [Full Text] [Related]

  • 15. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
    Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, Breiger D, Broxson E, Donahue B, Finlay JL, Goldwein JW, Heier LA, Johnson D, Mazewski C, Miller DC, Packer R, Puccetti D, Radcliffe J, Tao ML, Shiminski-Maher T, Children's Cancer Group.
    J Clin Oncol; 2005 Oct 20; 23(30):7621-31. PubMed ID: 16234523
    [Abstract] [Full Text] [Related]

  • 16. Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology.
    Laithier V, Grill J, Le Deley MC, Ruchoux MM, Couanet D, Doz F, Pichon F, Rubie H, Frappaz D, Vannier JP, Babin-Boilletot A, Sariban E, Chastagner P, Zerah M, Raquin MA, Hartmann O, Kalifa C, French Society of Pediatric Oncology.
    J Clin Oncol; 2003 Dec 15; 21(24):4572-8. PubMed ID: 14673044
    [Abstract] [Full Text] [Related]

  • 17. Modeling clinical outcome of children with autistic spectrum disorders.
    Coplan J, Jawad AF.
    Pediatrics; 2005 Jul 15; 116(1):117-22. PubMed ID: 15995041
    [Abstract] [Full Text] [Related]

  • 18. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G, Bamberg M, Jürgens H, Kortmann RD, Sörensen N, Wiestler OD, Göbel U.
    Klin Padiatr; 2004 Jul 15; 216(3):141-9. PubMed ID: 15175958
    [Abstract] [Full Text] [Related]

  • 19. Tumor recurrence and malignant progression of gangliogliomas.
    Majores M, von Lehe M, Fassunke J, Schramm J, Becker AJ, Simon M.
    Cancer; 2008 Dec 15; 113(12):3355-63. PubMed ID: 18988291
    [Abstract] [Full Text] [Related]

  • 20. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
    Gupta S, Johnson MM, Murthy R, Ahrar K, Wallace MJ, Madoff DC, McRae SE, Hicks ME, Rao S, Vauthey JN, Ajani JA, Yao JC.
    Cancer; 2005 Oct 15; 104(8):1590-602. PubMed ID: 16134179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.